Form 4: IDEAYA Biosciences Director Granted 20,000 Stock Options

IDEAYA Biosciences, Inc. Director Scott W. Morrison was granted 20,000 stock options with an exercise price of $21.78 per share, aligning his interests with shareholders.

Summary

• Scott W. Morrison, a Director of IDEAYA Biosciences, Inc. (IDYA), was granted 20,000 stock options.
• The stock options have an exercise price of $21.78 per share.
• The transaction date for the option grant was June 24, 2025.
• The options become fully vested on the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date, contingent on Mr. Morrison's continued service on the Board.
• The expiration date for these stock options is June 24, 2035.
• Following this transaction, Mr. Morrison directly beneficially owns 20,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a Form 4 filing for an option grant is routine, it signifies continued commitment and alignment of a key director with the company's future success, which is generally viewed favorably by investors.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, as the options gain value if the company's stock price increases.
• This is a standard form of executive and director compensation, indicating continued commitment and incentivization for long-term performance.

Future Outlook

The vesting schedule for the stock options indicates an expectation of continued service from Director Scott W. Morrison on the Board of IDEAYA Biosciences, Inc., aligning his long-term commitment with the company's future performance.

Industry Context

Stock option grants are a common compensation mechanism in the biotechnology and pharmaceutical industries, used to attract and retain key talent, including directors, and to incentivize long-term value creation. This grant is consistent with typical practices for aligning director interests with company performance.

Related Party Transactions

• Grant of 20,000 stock options to Scott W. Morrison, a Director of IDEAYA Biosciences, Inc., at an exercise price of $21.78 per share. This is a transaction between the company and a related party (a director).

Stakeholder Impact

• Shareholders: The grant of options to a director aims to align the director's financial interests with shareholder value creation, as the options become more valuable if the stock price increases.
• Employees: While not directly impacting all employees, such grants to leadership can signal confidence in the company's future, potentially boosting morale.

Next Steps

• The granted stock options will vest according to the specified schedule (earlier of first anniversary of grant or immediately prior to the Annual Meeting following grant), subject to continued service.

Key Dates

Keywords

IDEAYA Biosciences, IDYA, Scott W. Morrison, Stock Option Grant, Director Compensation, Insider Transaction, SEC Form 4, Equity Compensation, Biotechnology